Edition:
United States

Seres Therapeutics Inc (MCRB.OQ)

MCRB.OQ on NASDAQ Stock Exchange Global Select Market

9.51USD
22 Jun 2018
Change (% chg)

-- (--)
Prev Close
$9.51
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
51,843
52-wk High
$17.33
52-wk Low
$6.65

Select another date:

Wed, May 9 2018

BRIEF-Seres Therapeutics Reports Qtrly Loss Per Share Of $0.69

* SERES THERAPEUTICS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES OPERATIONAL UPDATES

BRIEF-Nestle Health Science Us Holdings, Inc Reports 16.97 Pct Stake In Seres Therapeutics Inc

* Nestle Health Science Us Holdings, Inc Reports 16.97 Pct Stake In Seres Therapeutics Inc As Of April 10, 2018 - SEC Filing Source text (https://bit.ly/2GSzKlq) Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Seres Therapeutics wins dismissal of investor lawsuit over drug study

Biopharmaceutical company Seres Therapeutics Inc has won the dismissal of a lawsuit claiming it misled investors about the potential of an oral microbiome therapeutic drug that it was developing.

BRIEF-Seres Therapeutics Qtrly Net Loss Of $29.0 Mln Vs $25.3 Mln

* SERES THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

BRIEF-Seres Therapeutics Says Has Cash, Cash Equivalents And Investments Of $171.3 Mln

* SERES THERAPEUTICS SAYS HAS CASH, CASH EQUIVALENTS AND INVESTMENTS OF $171.3 MILLION, AS OF SEPT 30, 2017 - SEC FILING Source text: (http://bit.ly/2qFSBN0) Further company coverage:

Select another date: